Ignite Creation Date:
2025-12-25 @ 2:20 AM
Ignite Modification Date:
2026-03-07 @ 2:26 AM
Study NCT ID:
NCT03757234
Status:
COMPLETED
Last Update Posted:
2020-07-07
First Post:
2018-11-27
Is Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
IV or IV/PO Omadacycline vs. IV/PO Levofloxacin for the Treatment of Acute Pyelonephritis
Sponsor:
Paratek Pharmaceuticals Inc
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2018-11-19
Start Date Type:
ACTUAL
Primary Completion Date:
2019-06-26
Primary Completion Date Type:
ACTUAL
Completion Date:
2019-07-24
Completion Date Type:
ACTUAL
First Submit Date:
2018-11-27
First Submit QC Date:
None
Study First Post Date:
2018-11-28
Study First Post Date Type:
ACTUAL
Results First Submit Date:
2020-06-08
Results First Submit QC Date:
None
Results First Post Date:
2020-07-07
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2020-07-02
Last Update Post Date:
2020-07-07
Last Update Post Date Type:
ACTUAL